RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus …

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus …

Add to Collection
RCTs DJ Stewart, JD Hilton, JMO Arnold, J Gregoire… - Gene therapy, 2006 - nature.com

Chapter : Section1, Section2
Journal Year : 2006
Cited by : 290

… of diabetes and previous percutaneous coronary interventions. If anything, this imbalance would bias against a benefit with VEGF gene therapy, since diabetes … 26 weeks of follow up for …..... Read More

Keywords : ['phase randomize control trial', 'nonrevascularizable ischemic heart disease', 'angiogenic gene therapy', 'versus', 'patient']
PubMed Link : https://www.nature.com/articles/3302802
Google Scholar Link : https://scholar.google.com/scholar?cites=11328173993250663888&as_sdt=5,31&sciodt=0,31&hl=en&num=20